← Leaderboards
Fadlo Raja Khuri
Emory University
$2,954,298
Attributed
$2,954,298
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2006–12$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$10,905,712 · 4
By mechanism
P01$9,823,636 · 2
P50$839,098 · 1
P30$242,978 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Paraskevi Giannakakou$12,786,350
- Wei Zhou$6,934,396
- Ronald Lloyd Braithwaite$12,724,385
- Henry Francis Edelhauser$10,202,841
- Shi-Yong Sun$12,583,440
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsProgramsMalignant NeoplasmsResearch PersonnelMalignant Neoplasm Of LungOperative Surgical ProceduresInstitutesBiologyPathway InteractionsCancer TherapyUniversitiesSignal PathwayOncologyAreaMolecularAntineoplastic AgentsEnvironmentBiomarkerFosteringNanotechnologyDrug DevelopmentDrug DiscoveryBaseCancer Control
Grant awards (21)
Modulation of the mTOR Pathway for Lung Cancer Treatment$249,999
P01 · FY2012 · CA · contact PI
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy$249,999
P01 · FY2012 · CA · contact PI
CAREER DEVELOPMENT PROGRAM$158,853
P50 · FY2011 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS (DDT)$76,082
P30 · FY2011 · CA · contact PI
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy$1,552,534
P01 · FY2010 · CA · contact PI
Modulation of the mTOR Pathway for Lung Cancer Treatment$385,887
P01 · FY2010 · CA · contact PI
CAREER DEVELOPMENT PROGRAM$180,126
P50 · FY2010 · CA · contact PI
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy$147,250
P01 · FY2010 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS (DDT)$87,077
P30 · FY2010 · CA · contact PI
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy$1,528,598
P01 · FY2009 · CA · contact PI
Modulation of the mTOR Pathway for Lung Cancer Treatment$347,806
P01 · FY2009 · CA · contact PI
CAREER DEVELOPMENT PROGRAM$176,703
P50 · FY2009 · CA · contact PI
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS (DDT)$79,819
P30 · FY2009 · CA · contact PI
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy$1,490,578
P01 · FY2008 · CA · contact PI
Modulation of the mTOR Pathway for Lung Cancer Treatment$339,926
P01 · FY2008 · CA · contact PI
CAREER DEVELOPMENT PROGRAM$176,290
P50 · FY2008 · CA · contact PI
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy$1,482,455
P01 · FY2007 · CA · contact PI
Modulation of the mTOR Pathway for Lung Cancer Treatment$338,854
P01 · FY2007 · CA · contact PI
CAREER DEVELOPMENT PROGRAM$147,126
P50 · FY2007 · CA · contact PI
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy$1,500,000
P01 · FY2006 · CA · contact PI
Modulation of the mTOR Pathway for Lung Cancer Treatment$209,750
P01 · FY2006 · CA · contact PI